Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Biotechnology and Bioengineering|August 25, 2015
Alleviating product inhibition in cellulase enzyme Cel7AMeera E Atreya, Kathryn L Strobel, Douglas S ClarkThe Journal of Biological Chemistry|July 26, 2015
Structural insights into the affinity of Cel7A carbohydrate-binding module for ligninKathryn L Strobel, Katherine A Pfeiffer, Harvey W Blanch, et al.Biotechnology and Bioengineering|December 1, 2015
Engineering Cel7A carbohydrate binding module and linker for reduced lignin inhibitionKathryn L Strobel, Katherine A Pfeiffer, Harvey W Blanch, et al.Biotechnology and Bioengineering|December 16, 2015
Simultaneous selection and counter-selection for the directed evolution of proteases in E. coli using a cytoplasmic anchoring strategyZachary M Carrico, Kathryn L Strobel, Meera E Atreya, et al.Biotechnology and Bioengineering|April 16, 2011
Chemotaxis increases vertical migration and apparent transverse dispersion of bacteria in a bench-scale microcosmKathryn L Strobel, Sara McGowan, Robert D Bauer, et al.Biotechnology and Bioengineering|May 22, 2015
Evaluating endoglucanase Cel7B-lignin interaction mechanisms and kinetics using quartz crystal microgravimetryKatherine A Pfeiffer, Hagit Sorek, Christine M Roche, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid TumorsMary Ellen Molloy, Richard J Austin, Bryan D Lemon, et al.Molecular Cancer Therapeutics|November 18, 2020
TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid TumorsRichard J Austin, Bryan D Lemon, Wade H Aaron, et al.Molecular Cancer Therapeutics|April 26, 2024
HPN328, a Trispecific T Cell-Activating Protein Construct Targeting DLL3-Expressing Solid TumorsMary E Molloy, Wade H Aaron, Manasi Barath, et al.Pageof 1